Adolescent Rural Cohort Study Hormones, Health, Education, Environments And Relationships
Funder
National Health and Medical Research Council
Funding Amount
$1,016,983.00
Summary
Adolescence is a time of major physical, emotional and social change, often characterised by risk taking and experimentation. Behaviours and decisions taken at this time of life will shape future health. This rural cohort study will for the first time will study the influence of pubertal hormones on behaviours, mental and physical health and general well being in adolescents.
A Phase III Trial Comparing Adjuvant Versus Salvage Radiotherapy For High Risk Patients Post Radical Prostatectomy
Funder
National Health and Medical Research Council
Funding Amount
$819,138.00
Summary
About half of all patients Treated with an operation to remove their prostate cancer have a high chance of the cancer coming back. Giving immediate radiotherapy to all patients will improve cure rates but does not benefit all men and can cause significant side effects. This study explores whether it is safe to wait and only give radiotherapy when there is a rising PSA after surgery indicating active cancer. A total of 470 men from Australasia will enter this study comparing the two approaches.
Bell’s palsy is the sudden onset of one-sided facial weakness of unknown cause. Patients cannot close their eyes and mouths properly; this interferes with eating and speaking. In adults, there is conclusive evidence that a short course of prednisolone, a steroid, can increase the number of patients who recover completely. This study will investigate at 10 centres in Australia and New Zealand whether prednisolone should be used in children as well.
The Ovarian Cancer Prognosis And Lifestyle (OPAL) Study: Long-term Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$871,657.00
Summary
Ovarian cancer affects 1500 women each year in Australia and 5-year survival is <45%. Affected women thus face a poor prognosis and often ask what they can do to improve this. There is no direct evidence whether a woman’s lifestyle might influence her outcomes, although data from breast cancer suggest this is possible. The OPAL Study is following 960 women with ovarian cancer to identify whether lifestyle is associated with long-term survival to provide evidence for women with this disease.
Improving Outcomes From Ovarian Cancer: Building The Evidence To Help Women Help Themselves
Funder
National Health and Medical Research Council
Funding Amount
$1,839,772.00
Summary
Ovarian cancer affects 1300 women each year in Australia and 5-year survival is <45%. Women with this cancer thus face a poor prognosis and many ask what they can do to improve this. There is no direct evidence whether a woman’s lifestyle might influence her outcomes, although data from breast cancer suggest this is possible. The OPAL Study will follow 1200 women with ovarian cancer to identify whether lifestyle is associated with survival to provide guidance for women with this disease.
SNAC1: A Randomised Trial Of Sentinel Node Based Management Versus Axillary Clearance For Women With Small Breast Cancers
Funder
National Health and Medical Research Council
Funding Amount
$366,663.00
Summary
SNAC1 will determine if sentinel node based management (a smaller operation removing a few lymph nodes) results in better quality of life and equivalent cure rates after 10 years follow-up compared with routine axillary clearance (a larger operation removing many lymph nodes) in over 1000 women with early breast cancer recruited to this large scale randomized trial from 2001 to 2005
Development And Validation Of A Health Policy Simulation Model For Type 1 Diabetes.
Funder
National Health and Medical Research Council
Funding Amount
$409,199.00
Summary
This proposal brings together an international multi-disciplinary team to develop and validate a health economic computer simulation model for type 1 diabetes and its complications. It examines the impact of diabetes on costs as well as quality of life. Outcomes generated by the model will inform health policy decisions regarding allocation of resources for people with type 1 diabetes such as cost-effectiveness analysis of new treatments and technologies.
Selective Estrogen Receptor Modulators - A New Adjunctive Treatment For Men With Schizophrenia?
Funder
National Health and Medical Research Council
Funding Amount
$816,603.00
Summary
One-third of people with schizophrenia do not respond well to antipsychotic medication treatment.There is an urgent need to develop new treatments.We have conducted world-first studies showing that estrogen treatment is highly successful in treating women with schizophrenia.Our research is a trial of SERM (selective estrogen receptor modulator), a new form of “brain estrogen” in men with persistent schizophrenia. We hope to reduce the disability caused by persistent psychotic symptoms.
Advance Care Planning In Incurable Cancer Patients With Disease Progression On First Line Chemotherapy: A Randomised Trial.
Funder
National Health and Medical Research Council
Funding Amount
$745,946.00
Summary
Advance care planning informs patient and care giver about end of life care options and assists patients to reflect on their goals, values and beliefs and to discuss and document their future choices. This randomised trial evaluates advance care planning in incurable cancer patients. The primary endpoint is the family member's view of the quality of death and compliance with known end of life wishes of the deceased patient. The costs of subsequent care are also recorded.
Living kidney donation remains a complex ethical issue. The expectation is that the risks to the donor are outweighed by the benefits to the donor and recipient. The long-term risks to the donor are however uncertain. This is an international prospective cohort study of 310 donors and 310 non-donors, including the recruitment of 85 donors and 85 non-donors in Australia. We will determine the long term risks on a kidney donor of a series of physical and psychological health outcomes.